Sino Biopharmaceutical Ltd.
0
0
0%

Financials

Income statement

Fundamentals currency is CNY
Fiscal date Jun 2021 Mar 2021 Dec 2020 Sep 2020
Total reported revenue 7.1B 7.2B 5.5B 5.5B
Cost of revenue 1.3B 1.4B 1.1B 1.3B
Gross profit 5.8B 5.8B 4.4B 4.2B
Operating expense
Research & development 1.0B 699.7M 386.4M
Selling general and admin 3.2B 3.5B 3.0B 2.9B
Other operating expenses 1.7B 69.0M 863.8M 158.3M
Operating income 1.9B 1.3B 755.6M 1.1B
Non operating interest income
Income 45.3M 54.0M -13.3M 54.5M
Expense 75.6M 71.7M 57.9M 91.1M
Other income expense
Pretax income 8.1B 2.8B 1.3B 1.2B
Tax provision 890.0M 446.9M -105.3M 239.8M
Net income 7.2B 2.4B 1.4B 946.2M
Basic EPS 0.1
Diluted EPS 0.1
Basic average shares 17.3B
Diluted average shares 17.8B
EBITDA 8.2B 2.9B 914.5M 1.2B
Net income from continuing op.
Minority interests -680.3M -480.9M -457.5M -308.8M
Preferred stock dividends -11.2M 123.8M 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 8 minutes

13:51
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
09:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 16:10
All times are displayed in the Asia/Hong_Kong timezone (HKT, UTC+08:00).